WHAN IN PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,830 KRW | -0.29% |
|
+1.77% | -8.05% |
| 2023 | Whan In Pharm Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2015 | Whanin Pharmaceutical Co. Ltd.(KOSE:A016580) added to Russell Global Index | CI |
| Sales 2024 * | 249B 181M 15.07B | Sales 2025 * | 271B 197M 16.43B | Capitalization | 211B 154M 12.79B |
|---|---|---|---|---|---|
| Net income 2024 * | 28B 20.36M 1.7B | Net income 2025 * | 30B 21.81M 1.82B | EV / Sales 2024 * | 0.71 x |
| Net cash position 2024 * | 35B 25.44M 2.12B | Net cash position 2025 * | 43.3B 31.48M 2.62B | EV / Sales 2025 * | 0.62 x |
| P/E ratio 2024 * |
9.2
x | P/E ratio 2025 * |
8.46
x | Employees | 553 |
| Yield 2024 * |
2.17% | Yield 2025 * |
2.17% | Free-Float | 59.11% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.29% | ||
| 1 week | +1.77% | ||
| Current month | -4.88% | ||
| 1 month | -5.27% | ||
| 3 months | -3.22% | ||
| 6 months | +2.22% | ||
| Current year | -8.05% |
1 week
13 540.00
14 340.00
1 month
13 460.0014 660.00
Current year
13 460.0015 570.00
1 year
12 410.0016 340.00
3 years
12 410.0023 550.00
5 years
9 950.0023 550.00
10 years
9 950.0029 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Won-Bum Lee
CEO | Chief Executive Officer | 49 | 01/06/01 |
Kwang-Sik Lee
CEO | Chief Executive Officer | 76 | 01/78/01 |
Ho-Chul Shin
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kwang-Sik Lee
CEO | Chief Executive Officer | 76 | 01/78/01 |
Won-Bum Lee
CEO | Chief Executive Officer | 49 | 01/06/01 |
Kyung-Seok Cho
BRD | Director/Board Member | 50 | 18/16/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 13,830 | -0.29% | 14,099 |
| 25/24/25 | 13,870 | 0.00% | 60,961 |
| 24/24/24 | 13,870 | +0.43% | 10,992 |
| 23/24/23 | 13,810 | +0.15% | 7,712 |
| 22/24/22 | 13,790 | +1.47% | 12,320 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
Whan In Pharm Co.,Ltd. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Companyâs products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The Company also involves in the real estate rental business.
Sector
Pharmaceuticals
Calendar
10/05/2024
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13,830
KRW
Average target price
21,000
KRW
Spread / Average Target
+51.84%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.05% | 153M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- A016580 Stock
